SARS-CoV-2 has displaced other seasonal respiratory viruses : Results from a prospective cohort study
Copyright © 2020. Published by Elsevier Ltd..
OBJECTIVES: The effect of SARS-CoV-2 on existing respiratory viruses in circulation and the overall burden of viral respiratory disease remains uncertain. Traditionally, severe viral respiratory disease disproportionally affects those with underlying chronic lung diseases. This study aimed to assess the impact of SARS-CoV-2 on the prevalence and clinical characteristics of respiratory virus disease in hospitalised adults.
METHODS: Data for this cohort study were from hospitalised adults who had multiplex PCR testing for respiratory viruses over several seasons in Hampshire, UK. Respiratory virus detection during the first epidemic peak of SARS-CoV-2 was compared to detection during the same time period across previous years.
RESULTS: 856 patients had multiplex PCR for respiratory viruses between March and May over 5 years. Before 2020, a non-SARS-CoV-2 virus was detected in 54% patients (202/371) compared to 4.1% (20/485) in 2020 (p < 0.0001). SARS-CoV-2 was associated with asthma or COPD exacerbations in a smaller proportion of infected patients compared to other viruses (1.0% vs 37%, p < 0.0001).
CONCLUSIONS: The emergence of SARS-CoV-2 was associated with substantial reductions in the circulation of seasonal respiratory viruses and large differences in the characteristics of viral-associated disease, including illness in a greater proportion of patients without underlying lung disease.
Errataetall: |
CommentIn: J Infect. 2021 Oct;83(4):496-522. - PMID 34320391 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:81 |
---|---|
Enthalten in: |
The Journal of infection - 81(2020), 6 vom: 01. Dez., Seite 966-972 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Poole, Stephen [VerfasserIn] |
---|
Links: |
---|
Themen: |
COVID-19 |
---|
Anmerkungen: |
Date Completed 07.01.2021 Date Revised 29.11.2021 published: Print-Electronic CommentIn: J Infect. 2021 Oct;83(4):496-522. - PMID 34320391 Citation Status MEDLINE |
---|
doi: |
10.1016/j.jinf.2020.11.010 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM317744356 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM317744356 | ||
003 | DE-627 | ||
005 | 20231225163917.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jinf.2020.11.010 |2 doi | |
028 | 5 | 2 | |a pubmed24n1059.xml |
035 | |a (DE-627)NLM317744356 | ||
035 | |a (NLM)33207254 | ||
035 | |a (PII)S0163-4453(20)30707-6 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Poole, Stephen |e verfasserin |4 aut | |
245 | 1 | 0 | |a SARS-CoV-2 has displaced other seasonal respiratory viruses |b Results from a prospective cohort study |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 07.01.2021 | ||
500 | |a Date Revised 29.11.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a CommentIn: J Infect. 2021 Oct;83(4):496-522. - PMID 34320391 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2020. Published by Elsevier Ltd. | ||
520 | |a OBJECTIVES: The effect of SARS-CoV-2 on existing respiratory viruses in circulation and the overall burden of viral respiratory disease remains uncertain. Traditionally, severe viral respiratory disease disproportionally affects those with underlying chronic lung diseases. This study aimed to assess the impact of SARS-CoV-2 on the prevalence and clinical characteristics of respiratory virus disease in hospitalised adults | ||
520 | |a METHODS: Data for this cohort study were from hospitalised adults who had multiplex PCR testing for respiratory viruses over several seasons in Hampshire, UK. Respiratory virus detection during the first epidemic peak of SARS-CoV-2 was compared to detection during the same time period across previous years | ||
520 | |a RESULTS: 856 patients had multiplex PCR for respiratory viruses between March and May over 5 years. Before 2020, a non-SARS-CoV-2 virus was detected in 54% patients (202/371) compared to 4.1% (20/485) in 2020 (p < 0.0001). SARS-CoV-2 was associated with asthma or COPD exacerbations in a smaller proportion of infected patients compared to other viruses (1.0% vs 37%, p < 0.0001) | ||
520 | |a CONCLUSIONS: The emergence of SARS-CoV-2 was associated with substantial reductions in the circulation of seasonal respiratory viruses and large differences in the characteristics of viral-associated disease, including illness in a greater proportion of patients without underlying lung disease | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a Influenza | |
650 | 4 | |a Molecular diagnostics | |
650 | 4 | |a Pneumonia | |
650 | 4 | |a Point-of-care testing | |
650 | 4 | |a Respiratory viruses | |
650 | 4 | |a SARS-CoV-2 | |
700 | 1 | |a Brendish, Nathan J |e verfasserin |4 aut | |
700 | 1 | |a Clark, Tristan W |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Journal of infection |d 1982 |g 81(2020), 6 vom: 01. Dez., Seite 966-972 |w (DE-627)NLM012791822 |x 1532-2742 |7 nnns |
773 | 1 | 8 | |g volume:81 |g year:2020 |g number:6 |g day:01 |g month:12 |g pages:966-972 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jinf.2020.11.010 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 81 |j 2020 |e 6 |b 01 |c 12 |h 966-972 |